Loading...
Symbols:
Loading...
Symbols:
Glaxosmithkline plc (GSK)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Glaxosmithkline plc (GSK)
207 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on GSK
- SA Editor Miriam Metzinger(17)
- SA Editor Eli Hoffmann(17)
- Derek Lowe(17)
- ChinaBio Today(16)
- Centient Biotech Investor(15)
Most popular authors
(tracked in watchlists)
- Philip Davis(591)
- Bill Cara(432)
- SA Editor Eli Hoffmann(386)
- Mike Stathis (338)
- Roger Nusbaum(325)
Most commented on authors
- Mike Stathis (61)
- SA Editor Eli Hoffmann(50)
- Derek Lowe(26)
- Andrew Mickey(25)
- Ohad Hammer(24)
- Nine Pharma Predictions for 2009
- Trial Results Don't Look Good for GlaxoSmithKline's Diabetes Drug
- China Biopharma News Back in the Spotlight
- Navigating the Micro-Cap Biotech Minefield
- 73 Decision Dates on Updated FDA Calendar
- Big Pharma Steps Up China Investment
- Regenerative Medicine: Big Pharma's Next Frontier
- Updated FDA Decision Date Calendar
- Highly Defensive ETFI: Lower Volatility, Higher Returns
- Boning Up on Amgen's D-mab for Osteoporosis
- Backlog of Decisions Is Building at the FDA
- Gold Miners: Biggest Drag on My Portfolio, Yet the Biggest Opportunity
- GlaxoSmithKline to Acquire Genelabs Technologies For $57M
- Glaxo and AFFiRiS Sign Alzheimer’s Disease Vaccine Deal
- Don't Buy Into Share Buybacks
- Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
- Ten Highest Yielding Pharma Stocks
- 'When There's Blood in the Streets', Buy Biotech Stocks
- FDA Publishes List of Potential Drug Risks
- Licensing Deal Is Imminent for ArQule
- Hard Times Hit Biotech
- Pfizer Cuts Back - But Is It Slimming Down for ImClone?
- Roche Covets Genentech for Good Reason
- Expiring Patents Ignite Biotech Boom
- Sinovac Launches New Version of Flu Vaccine
- GSK and Cellzome in Kinase Technology Alliance
- Latest FDA Report Highlights: 8 Drugs That Carry Potential Risks
- Yangtze River Delta Developing Huge R&D Base for Drug Companies
- 5 Big Pharma Cash Machines
- Why Dividend Investors View Stocks Differently
- Big Pharma Pipeline: Why So Dry?
- China's Hepatitis B Market to Double by 2012
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
- 2008 Q2 Portfolio Holdings: Berkowitz, Rodriguez & Pabrai
- Time to Invest in Pharmaceuticals?
- Companies With Recent, Innovative Product Approvals vs. Healthcare ETFs
- GlaxoSmithKline Trims Down Oncology Head Count
- Summer Slump for China Biotech News
- GlaxoSmithKline Makes Generics Deal to Penetrate Emerging Markets
- Wall Street Breakfast: Must-Know News
- Interview with Abba Horwitz, Old School Partners
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
1 new today)